Clinical Trial Update: A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients

View source ↗

Summary

A clinical trial evaluating the clinical benefit and safety of Anthrax Immune Globulin Intravenous (ANTHRASIL/AIGIV) in patients with inhalational anthrax; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inhalational Anthrax

Drugs mentioned

• ANTHRASIL (Anthrax immune globulin intravenous (AIGIV))

Snippet

Sponsor: Emergent BioSolutions | Conditions: Inhalational Anthrax | Status: NOT_YET_RECRUITING